Blog - Page 2 of 5628 - QualityStocks

WednesdayMay 13, 2026 9:10 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in BioMedWire editorial coverage highlighting the growing demand for real-time, noninvasive impairment detection technologies, with the company positioned as a differentiated player leveraging artificial intelligence and voice analysis to identify intoxication from brief speech recordings. The editorial underscores the limitations of conventional detection tools such as breathalyzers, blood draws and urine testing, noting MindBio’s focus on scalable, real-time assessment across multiple substances for potential applications in workplace safety, law enforcement, healthcare and public health.…

WednesdayMay 13, 2026 9:00 am

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Details Key Milestones and Future Drilling Plans at Emerging Growth Conference

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. The company is advancing an uncommon sedimentary phosphate project in northeast Nevada aimed at supplying direct-application organic fertilizer to U.S. agriculture markets. NOP’s unprocessed direct-application phosphate does not have to compete with the conventional chemical agricultural input industry, and has no large scale competition in North America. The project’s phosphate is intended for direct field application without chemical processing, potentially reducing capital requirements compared with conventional phosphate operations. Phosphate has now been added to the U.S. critical minerals list, increasing strategic attention on…

TuesdayMay 12, 2026 12:15 pm

QualityStocksNewsBreaks – Titan Partners Group LLC Expands Equity Research Division with Three Senior Analyst Appointments

Titan Partners, a division of American Capital Partners, has appointed Scott Buck, Kyle Bauser, Ph.D., and Adam Kelsey, CFA, to significantly expand its equity research platform across technology, healthcare, and energy, power and infrastructure. The three analysts bring more than 40 years of combined middle-market equity research experience, strengthening Titan’s sector-focused research capabilities as the firm continues to build its investment banking platform focused on underfollowed small- and mid-cap public companies. To view the full press release, visit https://ibn.fm/6KxBz About Titan Partners Titan Partners, a division of American Capital Partners, is a boutique investment bank specializing in tailored solutions for…

TuesdayMay 12, 2026 12:02 pm

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Commences 2026 Drilling at Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) has commenced drilling on the first hole of its 2026 exploration program at the Murdock Mountain Project, with initial deep drill hole MM26-7 designed as a 100-meter step-back from last fall’s MM25-1 to further evaluate the thickness, continuity and phosphate grade characteristics of the Meade Peak Upper Phosphatic Zone at depth. The company said minor technical drilling issues were identified and are being addressed by contractor FTE Drilling, with operations expected to resume shortly and no material delays anticipated. To view the full press release, visit https://ibn.fm/oieTp Nevada Organic…

TuesdayMay 12, 2026 11:51 am

QualityStocksNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) announced its placement in a BioMedWire editorial examining the evolution of GLP-1 therapies and emerging innovation in obesity and metabolic disease treatment. The editorial highlights SureNano’s subsidiary GlucaPharm Inc. and its GEP-44 program, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in the rapidly expanding GLP-1 market, as demand continues to grow for next-generation therapies targeting obesity, type 2 diabetes and related chronic conditions. To view the full press release, visit https://ibn.fm/pzQjm About SureNano Science Ltd. SureNano Science Ltd. (CSE: SURE) is a Canadian life sciences company focused on acquiring, developing, and advancing innovative pharmaceutical…

TuesdayMay 12, 2026 11:08 am

QualityStocksNewsBreaks – Qdrant Powers Sapu AI Platform Indexing 28 Million PubMed Abstracts to Accelerate Cancer Research

Qdrant’s vector database infrastructure supports the AI-powered research platform used by SAPU Bioscience, a subsidiary of Oncotelic Therapeutics Inc. (OTCQB: OTLC), enabling large-scale biomedical literature analysis SAPU’s platform has indexed 28 million PubMed abstracts into a single searchable collection, supporting AI-assisted research workflows and peer-reviewed scientific output The AI ecosystem aligns with Oncotelic’s broader strategy of integrating artificial intelligence, nanoparticle development and accelerated drug discovery platforms In a blog post by Daniel Azoulai, Qdrant highlighted how Sapu, an early-stage biopharmaceutical company developing treatments for hard-to-treat cancers, uses Qdrant Cloud infrastructure to power an AI research platform capable of indexing and querying all 28 million PubMed abstracts in a single searchable collection, helping accelerate biomedical…

TuesdayMay 12, 2026 10:45 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Reports Broad Gold Intercepts at Swanson Project

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. Figure 1: Plan View of Swanson Deposit with currently reported drill holes LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) reported results from its ongoing drilling program at the Swanson Gold Project, highlighting broad and continuous gold mineralization that supports expansion potential beyond the current mineral resource model and planned open-pit limits. Key intercepts included 2.95 g/t gold over 80.0 meters, 2.37 g/t gold over 88.05 meters and 1.29 g/t gold over 93.85 meters, with drilling targeting previously under-tested areas between 90 and 250 meters…

TuesdayMay 12, 2026 10:35 am

QualityStocksNewsBreaks – Bullish (NYSE: BLSH) to Acquire Equiniti in $4.2 Billion Transaction

Bullish (NYSE: BLSH) has entered into a definitive agreement to acquire Equiniti, the parent company of Notified and a global transfer agent and shareholder services provider, in a transaction valued at $4.2 billion. The acquisition is designed to position Bullish at the forefront of blockchain-native capital markets infrastructure by combining its institutional digital asset platform with Equiniti’s regulated transfer agent capabilities, which support nearly 3,000 public companies and more than 20 million verified shareholders. Bullish said the combination is intended to create a global transfer agent platform for tokenized securities, addressing what it views as a key infrastructure gap as…

TuesdayMay 12, 2026 10:30 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Announces Exercised Warrants and Debentures; Positioned to Capitalize on the Current Precious Metals Market

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF)and may include paid advertising. CMX Gold & Silver Corp., an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, just announced that a total of 3,320,000 warrants were exercised for the purchase of 3,320,000 common shares at $0.10 a share. Debentures aggregating $190,000 of principal were also converted into 1,520,000 shares at a conversion price of $0.125 a share. 1,520,000 shares were exercised by the settlement of $152,000 of debt, with cash proceeds of $180,000 from the exercise of warrants for 1,800,000 shares applied to working…

TuesdayMay 12, 2026 10:00 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) CEO Featured on TechMediaWire Podcast Discussing AI Voice Detection Platform

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Founder and CEO Justin Hanka joined the latest episode of the TechMediaWire Podcast to discuss the company’s artificial intelligence-driven voice analysis technology designed to detect drug and alcohol intoxication through noninvasive speech analysis. During the interview, Hanka outlined the limitations of traditional testing methods and described MindBio’s commercial focus on regulated workplace environments such as mining, where the company believes its scalable detection platform could improve safety by expanding real-time intoxication screening capabilities. To view the…

Site Search

Company Search